Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Authors
Keywords
-
Journal
Redox Biology
Volume 56, Issue -, Pages 102463
Publisher
Elsevier BV
Online
2022-09-02
DOI
10.1016/j.redox.2022.102463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Declining disease burden of HCC in the U nited S tates, 1992–2017: A population‐based analysis
- (2022) Jianglong Han et al. HEPATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PDSS2 inhibits the ferroptosis of vascular endothelial cells in atherosclerosis via activating Nrf2
- (2021) Kai Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature‐induced periodontitis
- (2021) Bo Zhang et al. JOURNAL OF PERIODONTAL RESEARCH
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload
- (2020) Jun-Kai Kao et al. ANNALS OF HEMATOLOGY
- Inhibition of Ferroptosis Attenuates Acute Kidney Injury in Rats with Severe Acute Pancreatitis
- (2020) Deliang Ma et al. DIGESTIVE DISEASES AND SCIENCES
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
- (2020) Adrienne M. Luoma et al. CELL
- ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3
- (2020) Yang-ling Li et al. ONCOGENE
- The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
- (2020) Matthias Pinter et al. JAMA Oncology
- Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx
- (2020) Lixing Li et al. Frontiers in Medicine
- Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis
- (2019) Priya Handa et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
- (2019) O Hamid et al. ANNALS OF ONCOLOGY
- Iron‐load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages
- (2019) Xiaorong Hu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer
- (2019) Hui Ren et al. Cancer Management and Research
- ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
- (2019) Liyuan Wang et al. CELL DEATH AND DIFFERENTIATION
- Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition
- (2019) Yujia Yuan et al. CLINICAL SCIENCE
- Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer
- (2019) Jie Yi et al. Annals of Translational Medicine
- Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro
- (2018) Wei-peng Su et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway
- (2018) Yun Zhou et al. Cancer Medicine
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Apolipoproteins, lipids and risk of cancer
- (2016) Signe Borgquist et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- (2016) A. Gabrielson et al. Cancer Immunology Research
- Myeloid cells in hepatocellular carcinoma
- (2015) Shanshan Wan et al. HEPATOLOGY
- Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial
- (2014) Hui-Ling Ko et al. Thoracic Cancer
- Bone marrow and the control of immunity
- (2011) Ende Zhao et al. Cellular & Molecular Immunology
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROS
- (2011) A. Phillip West et al. NATURE
- mRNA-Seq whole-transcriptome analysis of a single cell
- (2009) Fuchou Tang et al. NATURE METHODS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search